Ian Frazer
From Wikipedia, the free encyclopedia
Ian Hector Frazer (born January 6, 1953) is an Australian immunologist, best known for his work on the development of a cervical cancer vaccine, which works by protecting women from Human papillomavirus (HPV).
Frazer was born in Glasgow, Scotland. Frazer trained as a physician in Edinburgh, specialising in immunology. He emigrated to Melbourne in 1980 to research viral immunology and moved to Queensland in 1985 where he currently heads the University of Queensland Centre for Immunology and Cancer Research at the Princess Alexandra Hospital.
In 2005 Frazer and his research groups undertook clinical study of a vaccine against human papillomavirus, which was 100% effective in preventing common cervical cancers caused by the virus. The drug is named Gardasil and has been approved by the US Food and Drug Administration and has been approved for use in the European Union. Ian Frazer personally administered the first publicly available injection of the vaccine in Australia in August 2006.[1] He is also involved in a large clinical trial taking place in Australia and China of a therapeutic vaccine against genital warts.[2]
In January 2006 he was named Australian of the Year.[3] Also in that year, he received the Cancer Research Institute's William B. Coley Award for Distinguished Research in Basic and Tumor Immunology along with Harald zur Hausen. He was awarded the Florey Medal for biomedical research in March 2007.
| Preceded by Fiona Wood |
Australian of the Year 2006 |
Succeeded by Tim Flannery |
[edit] References
- ^ Pollard, R. One small jab, but a giant leap for womankind, Sydney Morning Herald August 29, 2006
- ^ Aussie of the Year announces new vaccine trial, UQ News February 7, 2006
- ^ Australian of the Year 2006 Professor Ian Frazer
The vaccine is not 100% effective in preventing cervical cancer. It is 100% effective in providing immunity against the strains 16 and 18 which cause 70-80% of cervical cancers.
